Interventional Pulmonologist and Managing Director, Barcelona, Spain
Biography
Dr. Antoni Rosell (Barcelona, 1963) Pulmonologist (1992), PhD in Medicine (2000), Diploma in Biostatistics (2004), European Certification in Respiratory Medicine (HERMES) (2009), and Professor of Medicine at the Universitat Autònoma de Barcelona (2021), he has held the position of Chief of Respiratory Endoscopy Unit of the Hospital Universitari de Bellvitge (Barcelona) between 2005 and 2018. Since then, he is the Clinical Director of the Thoracic Institute of the Hospital Universitari of the Germans Trias I Pujol Hospital (Barcelona), managing the Pulmonology Service and the Thoracic Surgery Service. He has made short stages in international hospitals and research centers between 1998 and 2013, learning autofluorescence, endobronchial ultrasound (EBUS), rigid bronchoscopy, and lung cancer screening programs. He has been the introducer in Spain of the EBUS, the autofluorescence bronchoscopy, and the non-electromagnetic navigation system (Archimedes©). During 2012-2018, he developed an international fellowship on interventional bronchoscopy. He is a referral in this field, specifically rigid bronchoscopy and stenting. He leads the Translational Pulmonology Research Group of the Germans Trias Research Institute (IGTP).
Dr. Rosell is a reviewer of research projects of various public health agencies and international journals. He published 22 articles in Q1, h-Index of 16, and is the co-author of 3 patents. Together with the group of chemists, an antibiofilm silver-eluting stent was developed and tested in an animal model. His research is focused on radiomics and radiogenomics applied in lung cancer screening, and he is participating in the International Lung Screen Trial (ISLT). He chaired the 3rd European Congress of the EABIP (European Association for Bronchology and Interventional Pulmonology) in 2015 and was the vice president of the World Conference on Lung Cancer (WCLC) in Barcelona (2019).